Clinical Trials on Unresectable Gastroesophageal Junction Adenocarcinoma in Sweden
Total 12 results
-
Lund University HospitalActive, not recruitingResectable Gastric and Gastroesophageal Junction AdenocarcinomaSweden, Norway
-
Eli Lilly and CompanyCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaItaly, United States, Spain, Ukraine, Germany, Greece, Czechia, Turkey, Belgium, Sweden, Canada
-
Lund University HospitalCompletedAdenocarcinoma of the Esophagus or Esophagogastric JunctionSweden
-
Umeå UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingQuality of Life | Surgery | Pancreas Adenocarcinoma | Chemotherapy Effect | Pancreas Cancer | Pancreas Neoplasm | Pancreas Disease | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic AdenocarcinomaSweden
-
AmgenZai Lab (China only)RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaCanada, Japan, United States, Korea, Republic of, China, Italy, Australia, Sweden, Spain, Taiwan, France, Belgium, Denmark, Thailand, Turkey, Czechia, Bulgaria, Brazil, Norway, Mexico, Poland, Estonia, Israel, Greece, Romania, Chile, Peru, Po... and more
-
Cancer Trials IrelandSouthampton Clinical Trials Unit; Region H Rigshospitalet; Centre Hospitalier...CompletedOesophageal Cancer | Adenocarcinoma of the Oesophagus | Adenocarcinoma of the Oesophago-gastric Junction | Oesophageal Tumours | Junctional TumoursIreland, United Kingdom, Denmark, France, Sweden
-
Institut für Klinische Krebsforschung IKF GmbH...Active, not recruitingGastroEsophageal Cancer | Adenocarcinoma of the StomachGermany
-
Erasmus Medical CenterDutch Cancer Society; Dutch Pancreatic Cancer GroupRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic AdenocarcinomaNetherlands, Sweden, Norway
-
Incyte CorporationRecruitingMetastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States, Canada, Belgium, France, Germany, Italy, China, Spain, Japan, United Kingdom, Netherlands, Switzerland, Austria, Denmark, Finland, Ireland, Israel, Norway, Sweden
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell CarcinomaUnited States, France, Canada, Spain, Italy, Belgium, Austria, Denmark, Germany, Australia, Israel, Russian Federation, Czechia, Norway, Poland, Romania, Japan, Argentina, Ireland, Greece, United Kingdom, Brazil, Sweden, Finland
-
Seagen Inc.TerminatedUterine Cervical Neoplasms | Stomach Neoplasms | Testicular Neoplasms | Carcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Endometrial Neoplasms | Gastroesophageal Junction CarcinomaUnited States, Canada, Spain, Sweden, United Kingdom
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway